Contents Menu

Currents status and prospects of autologous bone marrow cell infusion therapy for liver cirrhosis patients

The bulletin of the Yamaguchi Medical School Volume 56 Issue 1-2 Page 1-3
published_at 2009
A050056000101.pdf
[fulltext] 857 KB
Title
Currents status and prospects of autologous bone marrow cell infusion therapy for liver cirrhosis patients
Creators Terai Shuji
Source Identifiers
Creator Keywords
ABMi therapy bone marrow cell regeneration cell therapy liver cirrhosis
We developed a novel cell therapy (ABMi therapy) using autologous bone marrow cells for liver cirrhosis patients. Our study depends on the findings from basic studies using GFP/CCl4 models. Beginning in November 2003, we started clinical trials of ABMi therapy and found it to be safe and effective for liver cirrhosis patients. Multicenter trials in Japan and Korea have also shown the effectiveness of ABMi therapy. In this review, we discuss translational research for the development of ABMi therapy for liver cirrhosis patients.
Languages eng
Resource Type departmental bulletin paper
Publishers Yamaguchi University School of Medicine
Date Issued 2009
File Version Version of Record
Access Rights open access
Relations
[isVersionOf] [URI]http://ds.cc.yamaguchi-u.ac.jp/~bulletin/index.html
Schools 大学院医学系研究科(医学)